Xiaohong Han

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

Yuankai Shi, L. Wang, Baohui Han et al. · Annals of Oncology · 2017 · 338 citations

Medicine, Oncology, Pharmacotherapy +10

Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study

Yuankai Shi, Junling Li, Shucai Zhang et al. · PLoS ONE · 2015 · 205 citations · Full text

Medicine, Molecular Medicine, Oncology +14

Disturbed Gut-Liver axis indicating oral exposure to polystyrene microplastic potentially increases the risk of insulin resistance

Chunzhen Shi, Xiaohong Han, Wei Guo et al. · Environment International · 2022 · 201 citations · Full text

Life Sciences, Microbiology, Toxicology +17

Functional Genetic Variations in <i>Cytotoxic T-Lymphocyte Antigen 4</i> and Susceptibility to Multiple Types of Cancer

Tong Sun, Yifeng Zhou, Ming Yang et al. · Cancer Research · 2008 · 160 citations

Life Sciences, Genetics, Molecular Genetics +17

Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma

Jianfei Qian, Jin Xie, Sungyoul Hong et al. · Blood · 2007 · 122 citations · Full text

Medicine, Cancer Biology, Oncology +13